Testing a new injection for weight loss in obesity
Part of Hormones & metabolism clinical trials.
This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need to understand and sign a consent form.
- Your body mass index (BMI) must be between 23 and 40, depending on your health status.
- Your weight must have been stable for the past 12 weeks (not up or down by more than 5%).
- You cannot have type 1 or type 2 diabetes.
- You cannot have had weight loss surgery or liposuction in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called BGM1812 given as an injection. It is for healthy Chinese adults who are either at a normal weight or are overweight/obese but not diabetic. The study will see how the drug works in the body and check for side effects.
This study tests a new injectable medication (SYH2082) that works like GLP-1 and GIP drugs to see how safe it is and how your body handles it. You must be healthy with no diabetes, thyroid cancer risk, or recent major surgery.
This study tests a new weekly injection (BGM0504) to help people with obesity or overweight lose weight. It may be an option if you have not had success with diet and exercise alone and meet certain health criteria.
This trial tests a new injection called SYH2092 in healthy adults, not for treating a disease. Participation helps researchers understand how the drug works in the body and if it is safe. If you qualify, you may be compensated for your time.
This study tests an injectable medication called Olatorepatide to help people with overweight or obesity lose weight. It is only for people without diabetes who meet specific body mass index (BMI) requirements.
This trial tests if a new injection works the same as the approved version in overweight or obese adults. It may help if you are looking for a weight management treatment.
Hear when a new Healhty trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.